Trends in Medical Use and Abuse of Opioid Analgesics
CONTEXT Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available a...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2000-04, Vol.283 (13), p.1710-1714 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1714 |
---|---|
container_issue | 13 |
container_start_page | 1710 |
container_title | JAMA : the journal of the American Medical Association |
container_volume | 283 |
creator | Joranson, David E Ryan, Karen M Gilson, Aaron M Dahl, June L |
description | CONTEXT Pain often is inadequately treated due in part to reluctance about using
opioid analgesics and fear that they will be abused. Although international
and national expert groups have determined that opioid analgesics are essential
for the relief of pain, little information has been available about the health
consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics
and the trends in medical use and abuse of 5 opioid analgesics used to treat
severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in
the databases of the Drug Abuse Warning Network (source of abuse data) and
the Automation of Reports and Consolidated Orders System (source of medical
use data). PATIENTS Nationally representative sample of hospital emergency department admissions
resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of
drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%;
2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%;
1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and
a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During
the same period, the total number of drug abuse mentions per year due to opioid
analgesics increased from 32,430 to 34,563 (6.6%), although the proportion
of mentions for opioid abuse relative to total drug abuse mentions decreased
from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to
806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone
(15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain
does not appear to contribute to increases in the health consequences of opioid
analgesic abuse. |
doi_str_mv | 10.1001/jama.283.13.1710 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_211383105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>192551</ama_id><sourcerecordid>52216337</sourcerecordid><originalsourceid>FETCH-LOGICAL-a382t-b18d5010d637db6ed1debbe64c1453aa151827d3ab9beb64fbc905f223050ec63</originalsourceid><addsrcrecordid>eNpFkE1rwzAMhs3YWLtu9-0ywtg1nRTZsX0sZV_Q0Ut7DnbsDJc26eLmsH8_QzsqBJLQw4teMXaPMEUAfNmYnZkWiqaYUiJcsDEKUjkJrS7ZGECrXHLFR-wmxg2kQJLXbIQgheBajhlf9b51MQtt9uVdqM02W0efmdZlMzukrmuy5T50Ic2t2X77GOp4y64as43-7lQnbP32upp_5Ivl--d8tsgNqeKQW1ROAIIrSTpbeofOW-tLXiMXZAwKVIV0ZKy23pa8sbUG0RQFgQBflzRhT0fdfd_9DD4eqk039OmMWBWIpAhBJOjxBA12512178PO9L_Vv8cEPJ8AE5O_pjdtHeKZIyTNIWEPRyz99LzUhRBIf3rdZmY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211383105</pqid></control><display><type>article</type><title>Trends in Medical Use and Abuse of Opioid Analgesics</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Joranson, David E ; Ryan, Karen M ; Gilson, Aaron M ; Dahl, June L</creator><creatorcontrib>Joranson, David E ; Ryan, Karen M ; Gilson, Aaron M ; Dahl, June L</creatorcontrib><description>CONTEXT Pain often is inadequately treated due in part to reluctance about using
opioid analgesics and fear that they will be abused. Although international
and national expert groups have determined that opioid analgesics are essential
for the relief of pain, little information has been available about the health
consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics
and the trends in medical use and abuse of 5 opioid analgesics used to treat
severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in
the databases of the Drug Abuse Warning Network (source of abuse data) and
the Automation of Reports and Consolidated Orders System (source of medical
use data). PATIENTS Nationally representative sample of hospital emergency department admissions
resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of
drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%;
2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%;
1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and
a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During
the same period, the total number of drug abuse mentions per year due to opioid
analgesics increased from 32,430 to 34,563 (6.6%), although the proportion
of mentions for opioid abuse relative to total drug abuse mentions decreased
from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to
806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone
(15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain
does not appear to contribute to increases in the health consequences of opioid
analgesic abuse.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.283.13.1710</identifier><identifier>PMID: 10755497</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>Chicago, IL: American Medical Association</publisher><subject>Analgesics ; Analgesics, Opioid - therapeutic use ; Biological and medical sciences ; Drug abuse ; Drug Utilization - trends ; Fentanyl - therapeutic use ; Humans ; Hydromorphone - therapeutic use ; Medical sciences ; Meperidine - therapeutic use ; Morphine - therapeutic use ; Narcotics ; Neuropharmacology ; Opioid-Related Disorders - epidemiology ; Oxycodone - therapeutic use ; Pain - drug therapy ; Pharmacology. Drug treatments ; Retrospective Studies ; Risk Assessment ; Social Change ; Trends ; United States - epidemiology</subject><ispartof>JAMA : the journal of the American Medical Association, 2000-04, Vol.283 (13), p.1710-1714</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright American Medical Association Apr 5, 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a382t-b18d5010d637db6ed1debbe64c1453aa151827d3ab9beb64fbc905f223050ec63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.283.13.1710$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.283.13.1710$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,315,782,786,3344,27933,27934,76499,76502</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1313940$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10755497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joranson, David E</creatorcontrib><creatorcontrib>Ryan, Karen M</creatorcontrib><creatorcontrib>Gilson, Aaron M</creatorcontrib><creatorcontrib>Dahl, June L</creatorcontrib><title>Trends in Medical Use and Abuse of Opioid Analgesics</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>CONTEXT Pain often is inadequately treated due in part to reluctance about using
opioid analgesics and fear that they will be abused. Although international
and national expert groups have determined that opioid analgesics are essential
for the relief of pain, little information has been available about the health
consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics
and the trends in medical use and abuse of 5 opioid analgesics used to treat
severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in
the databases of the Drug Abuse Warning Network (source of abuse data) and
the Automation of Reports and Consolidated Orders System (source of medical
use data). PATIENTS Nationally representative sample of hospital emergency department admissions
resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of
drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%;
2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%;
1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and
a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During
the same period, the total number of drug abuse mentions per year due to opioid
analgesics increased from 32,430 to 34,563 (6.6%), although the proportion
of mentions for opioid abuse relative to total drug abuse mentions decreased
from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to
806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone
(15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain
does not appear to contribute to increases in the health consequences of opioid
analgesic abuse.</description><subject>Analgesics</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Drug abuse</subject><subject>Drug Utilization - trends</subject><subject>Fentanyl - therapeutic use</subject><subject>Humans</subject><subject>Hydromorphone - therapeutic use</subject><subject>Medical sciences</subject><subject>Meperidine - therapeutic use</subject><subject>Morphine - therapeutic use</subject><subject>Narcotics</subject><subject>Neuropharmacology</subject><subject>Opioid-Related Disorders - epidemiology</subject><subject>Oxycodone - therapeutic use</subject><subject>Pain - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Social Change</subject><subject>Trends</subject><subject>United States - epidemiology</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1rwzAMhs3YWLtu9-0ywtg1nRTZsX0sZV_Q0Ut7DnbsDJc26eLmsH8_QzsqBJLQw4teMXaPMEUAfNmYnZkWiqaYUiJcsDEKUjkJrS7ZGECrXHLFR-wmxg2kQJLXbIQgheBajhlf9b51MQtt9uVdqM02W0efmdZlMzukrmuy5T50Ic2t2X77GOp4y64as43-7lQnbP32upp_5Ivl--d8tsgNqeKQW1ROAIIrSTpbeofOW-tLXiMXZAwKVIV0ZKy23pa8sbUG0RQFgQBflzRhT0fdfd_9DD4eqk039OmMWBWIpAhBJOjxBA12512178PO9L_Vv8cEPJ8AE5O_pjdtHeKZIyTNIWEPRyz99LzUhRBIf3rdZmY</recordid><startdate>20000405</startdate><enddate>20000405</enddate><creator>Joranson, David E</creator><creator>Ryan, Karen M</creator><creator>Gilson, Aaron M</creator><creator>Dahl, June L</creator><general>American Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20000405</creationdate><title>Trends in Medical Use and Abuse of Opioid Analgesics</title><author>Joranson, David E ; Ryan, Karen M ; Gilson, Aaron M ; Dahl, June L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a382t-b18d5010d637db6ed1debbe64c1453aa151827d3ab9beb64fbc905f223050ec63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Analgesics</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Drug abuse</topic><topic>Drug Utilization - trends</topic><topic>Fentanyl - therapeutic use</topic><topic>Humans</topic><topic>Hydromorphone - therapeutic use</topic><topic>Medical sciences</topic><topic>Meperidine - therapeutic use</topic><topic>Morphine - therapeutic use</topic><topic>Narcotics</topic><topic>Neuropharmacology</topic><topic>Opioid-Related Disorders - epidemiology</topic><topic>Oxycodone - therapeutic use</topic><topic>Pain - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Social Change</topic><topic>Trends</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joranson, David E</creatorcontrib><creatorcontrib>Ryan, Karen M</creatorcontrib><creatorcontrib>Gilson, Aaron M</creatorcontrib><creatorcontrib>Dahl, June L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joranson, David E</au><au>Ryan, Karen M</au><au>Gilson, Aaron M</au><au>Dahl, June L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in Medical Use and Abuse of Opioid Analgesics</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2000-04-05</date><risdate>2000</risdate><volume>283</volume><issue>13</issue><spage>1710</spage><epage>1714</epage><pages>1710-1714</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>CONTEXT Pain often is inadequately treated due in part to reluctance about using
opioid analgesics and fear that they will be abused. Although international
and national expert groups have determined that opioid analgesics are essential
for the relief of pain, little information has been available about the health
consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics
and the trends in medical use and abuse of 5 opioid analgesics used to treat
severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in
the databases of the Drug Abuse Warning Network (source of abuse data) and
the Automation of Reports and Consolidated Orders System (source of medical
use data). PATIENTS Nationally representative sample of hospital emergency department admissions
resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of
drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%;
2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%;
1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and
a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During
the same period, the total number of drug abuse mentions per year due to opioid
analgesics increased from 32,430 to 34,563 (6.6%), although the proportion
of mentions for opioid abuse relative to total drug abuse mentions decreased
from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to
806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone
(15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain
does not appear to contribute to increases in the health consequences of opioid
analgesic abuse.</abstract><cop>Chicago, IL</cop><pub>American Medical Association</pub><pmid>10755497</pmid><doi>10.1001/jama.283.13.1710</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0098-7484 |
ispartof | JAMA : the journal of the American Medical Association, 2000-04, Vol.283 (13), p.1710-1714 |
issn | 0098-7484 1538-3598 |
language | eng |
recordid | cdi_proquest_journals_211383105 |
source | MEDLINE; American Medical Association Journals |
subjects | Analgesics Analgesics, Opioid - therapeutic use Biological and medical sciences Drug abuse Drug Utilization - trends Fentanyl - therapeutic use Humans Hydromorphone - therapeutic use Medical sciences Meperidine - therapeutic use Morphine - therapeutic use Narcotics Neuropharmacology Opioid-Related Disorders - epidemiology Oxycodone - therapeutic use Pain - drug therapy Pharmacology. Drug treatments Retrospective Studies Risk Assessment Social Change Trends United States - epidemiology |
title | Trends in Medical Use and Abuse of Opioid Analgesics |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T01%3A57%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20Medical%20Use%20and%20Abuse%20of%20Opioid%20Analgesics&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Joranson,%20David%20E&rft.date=2000-04-05&rft.volume=283&rft.issue=13&rft.spage=1710&rft.epage=1714&rft.pages=1710-1714&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.283.13.1710&rft_dat=%3Cproquest_pubme%3E52216337%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211383105&rft_id=info:pmid/10755497&rft_ama_id=192551&rfr_iscdi=true |